An 80-year-old male was diagnosed with carcinoma in the lung with multiple bony metastases and had been prescribed pain medications as per World Health Organization analgesic ladder guidelines. However, he was not getting adequate pain relief and there were difficulties in titration of the morphine doses on an outpatient basis. Therefore, he was hospitalized for dose titration of oral morphine and was coprescribed amitriptyline and ranitidine. During the titration of the analgesic dose, he developed severe symptoms of morphine overdose. He was immediately treated with intravenous naloxone. After prolonged infusion of naloxone, he achieved his baseline vital parameters without any permanent sequel to the overdose event. This case report describes the possible causes of oral morphine overdose in the elderly and its successful treatment. To prevent such complications, one has to be very cautious of other factors such as drug interactions, particularly in the elderly.
Wiffen PJ, McQuay HJOral morphine for cancer pain. Cochrane Database Syst Rev . 2007;(4):CD003868.
2.
World Health Organization.Cancer Pain Relief . Geneva, Switzerland: World Health Organization; 1986.
3.
Ventafridda V., Tamburini M., Caraceni A., De Conno F., Naldi F.A validation study of the WHO method for cancer pain relief. Cancer. 1987;59:851-856.
4.
Zech DFJ , Grond S., Lynch J., Hertel D., Lehmann KAValidation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain . 1995;63:65-76.
5.
Expert Working Group of the European Association for Palliative Care.Morphine in cancer pain: modes of administration . BMJ. 1996;312:823-826.
6.
Schug SA, Zech D., Grond S., Jung H., Meuser T., Stobbe B.A long term survey of morphine in cancer pain patients. J Pain Symptom Manage. 1992;7:259-266.
7.
Portenoy RKAdjuvant analgesics in pain management. In Doyle D, Hanks GWC, MacDonald N, eds. Oxford Textbook of Palliative Medicine. Oxford, UK: Oxford University Press; 1993:187-203.
8.
Foley KMCurrent controversies in opioid therapy. In Foley KM, Inturrisi CE, eds. Advances in Pain Research and Therapy. Vol 8: Opioid Analgesics in the Management of Cancer Pain. New York, NY: Raven Press; 1986:3-11.
9.
Twycross RGOpioid analgesics in cancer pain: current practice and controversies . Cancer Surv. 1988;7:29-53.
10.
Portenoy RK , Coyle N.Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Symptom Manage. 1990;5:307-319.
11.
McQuay HJThe logic of alternative routes. J Pain Symptom Manage. 1990;5:75-77.
Conno F., Caraceni A., Martini C., Spoldi E., Salvetti M., Ventafridda V.Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine . Pain. 1991;47:337-339.
16.
Ueyema H., Nishimura M., Tashiro C.Naloxone reversal of nystagmus associated with intrathecal morphine administration . Anesthesiology. 1992;76:153.
17.
Krenn H., Jellinek H., Haumer H., Oczenski W., Fitsgerald R.Naloxone-resistant respiratory depression and neurological eye symptoms after intratechal morphine. Anesth Analg. 2000;91:432-433.
18.
Braun SF, Delle M.Morphine metabolism in man. Clin Pharmacol Ther. 1974;16:51-57.
19.
McQuay HJ, Carroll D., Faura CC, Gavaghan DJ, Hand CW, Moore RAOral morphine in cancer pain: influences on morphine and metabolite concentration. Clin Pharmacol Ther . 1990;48:236-244.
20.
Ball M., Moore RA, Fisher A., McQuay HJ, Allen MC, Sear J.Renal failure and the use of morphine in intensive care. Lancet. 1985;1:784-786.
21.
Redfern N.Dihydrocodeine overdose treated with naloxone infusion. BMJ . 1983;287:751-752.
22.
Woolner DF, Winter D., Frendin TJ, Begg EJ, Lynn KL, Wright GJRenal failure does not impair the metabolism of morphine. Br J Clin Pharmacol. 1986;22:55-59.
23.
Osborne RJ, Joel SP, Slevin MLMorphine intoxication in renal failure: the role of morphine 6-glucuronide . BMJ. 1986;292:1548-1549.
24.
Sawe J.High-dose morphine and methadone in cancer patients: clinical pharmacokinetic considerations of oral treatments. Clin Pharmacokinet. 1986;11:87-106.
25.
Caracloc-Davies THOpiate toxicity in elderly patients. BMJ. 1981;283:905-906.
26.
Oslen GD, Bennet WM, Porter GAMorphine and phenytoin binding to plasma proteins in renal and hepatic failure . Clin Pharmacol Ther. 1975;17:677-684.
27.
Hanes SD, Franklin M., Kuhl DA, Headley ASProlonged opioid antagonism with naloxone in chronic renal failure . Pharmacotherapy. 1999;19:897-901.
28.
Sauter K., Kaufman HH, Bloomfield SM, Cline S., Banks D.Treatment of high-dose intrathecal morphine overdose. J Neurosurg . 1994;81:143-146.
29.
Groudine SB, Cresanti-Dakins C., Lumb PDSuccessful treatment of a massive intrathecal morphine overdose. Anesthesiology. 1995;82:292-295.
30.
Perrot G., Muller A., Laugner B.Accidental overdose of intrathecal morphine: treatment with intravenous naloxone alone. Ann Fr Anesth Reanim. 1983 ;2:412-414.
Kreitzer JM , Kirshenbaum LP, Eisenkraft JBSafety of PCA devices . Anesthesiology . 1989;70:881.
35.
Poklis A., Edinboro LE, Wohler AS, Presswalla F., Barron D.Fatal morphine poisoning in a child due to accidental oral ingestion . Forensic Sci Int. 1995;76:55-59.
36.
Chan HS, Leung A., Cohen Mah.Unexpected effects of a single dose of oral morphine. J Hong Kong Med Assoc. 1990;42:3.
37.
Wahlstrom A. , Lenhammar L., Ask B., Rane A.Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation . Pharmacol Toxicol. 1994;75:23-27.
38.
Hara Y., Nakajima M., Miyamoto K., Yokoi T.Morphine glucuronosyltransferase activity in human liver microsomes is inhibited by a variety of drugs that are co-administered with morphine . Drug Metab Pharmacokinet. 2007;22: 103-112.
39.
Aasmundstad TA, Storset P.Influence of ranitidine on the morphine-3-glucuronide to morphine-6-glucuronide ratio after oral administration of morphine in humans . Hum Exp Toxicol. 1998 ;17:347-352.
40.
Martinez-Abad M., Delgado Gomis F., Ferrer JM, Morales-Olivas FJRanitidine-induced confusion with concomitant morphine. Drug Intell Clin Pharm . 1988; 22:914-915.
41.
Ismail R.CYP2D6 genotype and phenotype relationship in South Indians. J Postgrad Med. 2006;52:245.
42.
Naveen AT, Prasanna T., Farzana BL, Rajan S., Adithan C.CYP2D6 genotype and phenotype relationship in South Indians. J Postgrad Med. 2006;52: 253-256.
43.
Naveen AT, Adithan C., Soya SS, Gerard N., Krishnamoorthy R.CYP2D6 genetic polymorphism in South Indian populations. Biol Pharm Bull. 2006;29: 1655-1658.
